THE Health Department has
released a new Emergency
Treatment Program which provides
for medicines such as Penthrox
(methoxyflurane) to be listed as a
special pharmaceutical product
under section 100AA, for supply as
a doctor’s bag item for emergency
treatment.
Pentrhox is methoxyflurane liquid
for inhalation 999.9mg per g 3ml
(with inhaler) and is not available
for prescribing as a general
pharmaceutical benefit but is
approved for emergency treatment
by doctors or in hospital.
“Availablility on prescription for
supply in the usual way would be
inappropriate as it would allow for
the direct supply of methoxyflurane
to community-based patients and
as such has the potential for use
without supervision by personnel
trained in its use,” an official
statement said.
The change is effective 01 May
and will be administered the same
was as other Doctor’s Bag items.The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.